Drugs News and Research

RSS

Researchers identify new gene that may have ability to prevent HIV

A team of researchers led by King's College London has for the first time identified a new gene which may have the ability to prevent HIV, the virus that causes AIDS, from spreading after it enters the body.

19 Sep 2013

Gout: An Interview with Dr. Lawrence Edwards, Chairman and CEO of GUAES

Gout is the most common form of inflammatory arthritis that affects adults. It's a disease caused by the presence of uric acid crystals in and around the joints. It's a disease that's becoming more and more common. It probably has doubled in its prevalence worldwide over the past twenty to thirty years.

18 Sep 2013

First Edition: September 18, 2013

Today's headlines include reports about the Census Bureau's latest figures on the nation's uninsured as well as Congressional Budget Office long-term deficit projections and how that news fits into events in the ongoing Capitol Hill budget battles.

18 Sep 2013

LSDF announces Proof of Concept grants to speed up promising health-related technologies

For-profit and non-profit organizations in Washington state will receive $1.25M in Proof of Concept grant funding to accelerate the translation of promising health-related technologies from concept to commercialization, the Life Sciences Discovery Fund (LSDF) announced today.

18 Sep 2013

New series of lectures focus on rodents, medicines and drug developments

Rodents, medicines and drug developments are all on the agenda during a new series of public lectures being staged by the University of Greenwich's Faculty of Engineering & Science.

18 Sep 2013

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

Boehringer Ingelheim and Eli Lilly and Company today announced they will feature five oral and 12 poster presentations for linagliptin and the investigational compound empagliflozin* at the 49th Annual Meeting of the European Association for the Study of Diabetes (EASD) which will take place in Barcelona, from 23 – 27 September. The presentations will add to the already existing body of data on safety and efficacy of these two compounds.

18 Sep 2013

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

GW Pharmaceuticals plc announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy.

18 Sep 2013

Handheld device for diagnosing early signs of osteoporosis

A handheld device for diagnosing the early signs of osteoporosis could be available for clinical use within five years.

18 Sep 2013

Intra-articular hyaluronic acid injections safe, effective for patients with knee osteoarthritis

A new meta-analysis of 29 randomized studies involving more than 4,500 patients with knee osteoarthritis found that intra-articular hyaluronic acid injections provided significant improvement in pain and function compared to saline injections.

18 Sep 2013

NHCS researchers discover potential cure for long QT syndrome 2

The National Heart Centre Singapore research team has successfully and completely reversed the effects of the hERG (human ether-a-go-go-related gene) mutation in long QT syndrome 2 in patient-specific heart cells, scoring a world's first.

18 Sep 2013

Researchers develop synthetic peptide that could be a new class of drugs for heart disease

Researchers at the University of Alberta have developed a synthetic peptide that could be the first in a new class of drugs to treat heart disease, high blood pressure and diabetes.

18 Sep 2013

Cardiovascular mortality in schizophrenia may be underestimated

Cardiovascular causes account for about a quarter of deaths of patients with schizophrenia and may also contribute to the high rate of unexplained deaths, say researchers.

17 Sep 2013

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib, an investigational inhibitor of polo-like kinase, being evaluated for the treatment of patients aged 65 or older with previously untreated acute myeloid leukemia, ineligible for intensive remission induction therapy.

17 Sep 2013

UCSF neuroscientist wins Barancik Prize for multiple sclerosis research

Neuroscientist Jonah Chan, PhD, at the University of California, San Francisco, is the first recipient of a new international prize launched to recognize innovation and progress in multiple sclerosis research.

17 Sep 2013

PCI announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging

Packaging Coordinators, Inc. (PCI), a global supplier of pharmaceutical commercial packaging solutions and clinical trials services today announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging. The company’s new service offering is outlined in a new white paper that is available to download via PCI anti-counterfeiting white paper and details its innovative identification solution, which uses a unique identification code on each pack, generated and applied by the packer.

From Packaging Coordinators Inc. (PCI) 17 Sep 2013

Dendreon Gets Green Light In Europe

...

17 Sep 2013

Dendreon Gets Greenlight In Europe

...

17 Sep 2013

Video demonstrates high throughput screening of cellular bioenergetics of multiple cell lines

INTEGRA has published a video demonstrating how its VIAFLO 96 handheld electronic pipette, used in conjunction with the Seahorse Bioscience XF96 Extracellular Flux Analyzer, provides high throughput screening of the cellular bioenergetics of multiple cell lines.

From INTEGRA Biosciences 17 Sep 2013

New analysis finds that EU member states identify 13 directives for patient safety

Europe is at the forefront of acknowledging the importance of patient safety and risk management. Eight to 10 percent of patients in the region are subjected to healthcare-associated infections and medication or prescription errors. Around 30 to 40 percent of these issues are preventable, and healthcare institutions have rolled out several initiatives for reporting and learning systems, as well as patient safety directives. Denmark in particular has shown considerable progress, followed closely by the U.K. and France.

17 Sep 2013

Using Serialization to Prevent Counterfeiting in the Pharmaceutical Industry

News-Medical speaks to Sue Miles about the dangers of counterfeit pharmaceutical products and how PCI are reducing the risk of counterfeiting during transit.

From Packaging Coordinators Inc. (PCI) 17 Sep 2013

Drugs News and Research

Researchers identify new gene that may have ability to prevent HIV

Gout: An Interview with Dr. Lawrence Edwards, Chairman and CEO of GUAES

First Edition: September 18, 2013

LSDF announces Proof of Concept grants to speed up promising health-related technologies

New series of lectures focus on rodents, medicines and drug developments

Efficacy and safety data on linagliptin and investigational compound empagliflozin* in various diabetes subpopulations presented by Boehringer Ingelheim and Eli Lilly and Company

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

Handheld device for diagnosing early signs of osteoporosis

Intra-articular hyaluronic acid injections safe, effective for patients with knee osteoarthritis

NHCS researchers discover potential cure for long QT syndrome 2

Researchers develop synthetic peptide that could be a new class of drugs for heart disease

Cardiovascular mortality in schizophrenia may be underestimated

FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's volasertib

UCSF neuroscientist wins Barancik Prize for multiple sclerosis research

PCI announces innovative developments in its anti counterfeiting initiatives for pharmaceutical packaging

Dendreon Gets Green Light In Europe

Dendreon Gets Greenlight In Europe

Video demonstrates high throughput screening of cellular bioenergetics of multiple cell lines

New analysis finds that EU member states identify 13 directives for patient safety

Using Serialization to Prevent Counterfeiting in the Pharmaceutical Industry

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News